期刊文献+

肝门部胆管癌的治疗现状 被引量:6

原文传递
导出
摘要 肝门部胆管癌(Hilarcholangiocarcinoma,HCC)是指发生于胆囊管开口以上的肝总管和左右肝管的黏膜上皮癌,亦称高位胆管癌或上段胆管癌。1965年,Klatskin首先描述了胆管分叉部腺癌的临床病理特点,故又将肝门部胆管癌称为Klatskin瘤。肝门部胆管癌隶属肝外胆管癌范畴,占肝外胆管癌的50%-75%。HCC早期诊断较为困难,误诊率高、手术切除率低、预后极差。目前全世界公认的最有效的胆管癌治疗措施是早期确诊并行根治性切除,除此以外,姑息性减黄和综合治疗也起到了一定作用。
出处 《国际外科学杂志》 2012年第5期296-298,共3页 International Journal of Surgery
  • 相关文献

参考文献13

  • 1Bismuth H, Nakache R, Diamond T, et al. Management strategies in resection for hilar cholangiocarcinoma [ J]. Ann Surg, 1992, 215(1): 31-35.
  • 2李惠珍 Aqeel Ahmed 傅华群.胆管癌的早期诊断方法及其治疗进展[J].国际外科学杂志,2009,36(8):550-553. 被引量:3
  • 3Uchiyama K, Nakai T, Tani M, et al. Indications for extended hepatectomy in the management of stage IV hilar cholangiocarcino- ma[J].ArchSurg, 2003, 138(9): 1012-1016.
  • 4许戈良.肝门胆管癌手术进展与争论[J].世界华人消化杂志,2008,16(25):2793-2796. 被引量:2
  • 5张永杰,俞文隆,杨珏,史嵩.肝门部胆管癌外科治疗的选择与疗效[J].中华肝胆外科杂志,2008,14(9):596-600. 被引量:14
  • 6Pichlmayr R, Weimann A, Klempnauer J, et al. Surgical treat-merit in proximal bile duct cancer. A single-center experience[ J]. Ann Surg, 1996, 224(5) : 628-638.
  • 7Heimbach JK, Gores GJ, Haddock MG, et al. Predictors of dis- ease recurrence following neoadjuvant chemoradiotherapy and liver transplantation for unresectable perihilar cholangiocarcinoma [J].Transplantation, 2006, 82 ( 12 ) : 1703-1707.
  • 8Rea DJ, Heimbaeh JK, Rosen CB, et al. Liver transplantation with neoadjuvant chemoradiation is more effective than resection for hilm" cholangiocarcinoma[J]. Ann Surg, 2005, 242(3): 451-458.
  • 9Unno M, Okumoto T, Katayose Y, et al. Preoperative assessment of hilar cholangiocarcinoma by multidetector row computed tomo- graphy [J].J Hepatobiliary Pancreat Surg, 2007, 14 ( 5 ) : 434-440.
  • 10Tsavaris N, Kosmas C, Gouveris P, et al. Weekly gecitabine for the treatment of biliary tract and gallbladder cancer [ J ]. Invest New Drug, 2004, 22(2):193-198.

二级参考文献16

  • 1Burke EC,Jarnagin WR, Hochwald SN, et al. Hilar Cholangio carcinoma: patterns of spread, the importance of hepatic resec tion for curative operation, and a presurgical clinical staging system. Ann Surg, 1998,228:385-394.
  • 2Capussotti L, Muratore A, Polastri R, et al. Liver resection for hilar cholangiocarcinoma-in hospital mortality and longterm survival. J Am Coil Surg, 2002,195:641-647.
  • 3Kondo S, Hirano S, Ambo Y, Tanaka E, Okushiba S, Morikawa T, Katoh H. Forty consecutive resections of hilar cholangiocarcinoma with no postoperative mortality and no positive ductal margins: results of a prospective study. Ann Surg 2004; 240:95-101.
  • 4Tabata M, Kawarada Y, Yokoi H, Higashiguchi T, Isaji S. Surgical treatment for hilar cholangiocarcinoma. J Hepatobiliary Pancreat Surg 2000; 7: 148-154.
  • 5Liu CL, Fan ST, Lo CM, Tso WK, Lam CM, Wong J. Improved operative and survival outcomes of surgical treatment for hilar cholangiocarcinoma. Br J Surg 2006; 93:1488-1494.
  • 6Sewnath ME, Karsten TM, Prins MH, Rauws EJ, Obertop H, Gouma DJ. A meta-analysis on the efficacy of preoperative biliary drainage for tumors causing obstructive jaundice. Ann Surg 2002; 236: 17-27.
  • 7Lai EC, Lau WY. Aggressive surgical resection for hilar cholangiocarcinoma. ANZ J Surg 2005; 75: 981-985.
  • 8Nagino M, Nimura Y, Kamiya J, Kondo S, Kanai M. Selective percutaneous transhepatic embolization of the portal vein in preparation for extensive liver resection: the ipsilateral approach. Radiology 1996; 200:559-563.
  • 9Makuuchi M, Thai BL, Takayasu K, Takayama T, Kosuge T, Gunven P, Yamazaki S, Hasegawa H, Ozaki H. Preoperative portal embolization to increase safety of major hepatectomy for hilar bile duct carcinoma: a preliminary report. Surgery 1990; 107:521-527.
  • 10Kawarada Y, Das BC, Naganuma T, Tabata M, Taoka H. Surgical treatment of hilar bile duct carcinoma: experience with 25 consecutive hepatectomies. J Gastrointest Surg 2002; 6:617-624.

共引文献15

同被引文献92

引证文献6

二级引证文献54

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部